Formula: C6H21N3O2
Exact Mass: 287.163 Da
Log P: 2.043
Acidic pKa: 13
Basic pKa: 9.57
Typical bioanalysis workflows for small molecules use organic solvents to precipitate proteins and extract the analyte(s). Sometimes, extra clean-up steps, including liquid-liquid extraction (LLE) or solid phase extraction (SPE), are needed to further remove the matrix and enrich analytes to satisfy sensitivity, accuracy, and precision requirements. However, the method development for bioanalysis is rather challenging. Some operating procedures are tedious and difficult to speed up and scale up.
Biotage offers ISOLUTE® SLE+ Supported Liquid Extraction (SLE) technology, to extract and clean analyte(s) from the biomatrix in one step. SLE is analogous to LLE but uses a polar solid media (a modified form of diatomaceous earth) as a physical support to allow the aqueous samples to spread over the surface in a thin layer. When the non-water miscible solvent passes through the bed, the analytes partition into the organic solvent, while the aqueous preferring matrix components remain in the aqueous layer on the surface. Like SPE, SLE relies on a solid phase to extract samples and is easily compatible with labora- tory automation. More importantly, SLE only requires sample pretreatment, load, wait, and elute steps, providing a simpler and faster solution to enrich the organic soluble analytes.
This application note demonstrates the ISOLUTE® SLE+ automa- tion workflow to process plasma samples prior to LC-MS/MS analysis. Zolmitriptan (figure 1), a selective serotonin receptor agonist, was spiked into plasma to mimic the biological samples for PK/PD study and used to evaluate the performance of the workflow. The Biotage® Extrahera™ Classic sample preparation workstation was used to automatically perform all the extraction steps. Our results indicated that this automated workflow offers high analyte recoveries, minimized matrix effect, excellent intra and inter plate precision and accuracy, and significantly reduced bench labor time.
Bioanalytical labs focusing on pre-clinical analysis often follow GLP procedures. As more labs move towards automation, understanding GLP requirements is pertinent. While using the Biotage® Extrahera™ Classic to efficiently process samples, the associated GLP software can be applied to maintain sample integrity and traceability necessary for regulatory focused environments. With the GLP software, the Extrahera™ Classic provides the connectivity needed to export sample data to a network repository where imported data can be securely stored, tracked, and effectively managed. The combination of the user account management, remote viewing, and e-mail notifications further ensures selective analyst access for status run updates, alerts, and method development governance.
The ISOLUTE® SLE+ automation workflow is ideal for small molecule bioanalysis in discovery, preclinical, and clinical research arenas. It can also be used in other LC-MS/MS assays for analytes preferring organic solvents to aqueous. With consideration of biofluid viscosity and sample homogenization (using Biotage® Lysera), this workflow is compatible with all biofluids (e.g., plasma, serum, urine, whole blood, oral fluid, etc.) and non-liquid samples (e.g. cells, tissues). The ISOLUTE® SLE+ plate (or cartridge) is open to manual operation, providing a great solution for all laboratories with manual or automated workflows.
Zolmitriptan
Plasma samples (Human K2EDTA) were processed using the ISOLUTE® SLE+ workflow using the Biotage® Extrahera™ Classic (96 configuration) and the TurboVap® 96 Dual, Figure 2.
Figure 2. ISOLUTE® SLE+ automation workflow for sample preparation in bioanalysis.
* Liquid transfer in steps 1 and 4 can be conducted by liquid handlers, which may further reduce the bench operation time.
ISOLUTE® SLE+ 200 µL Supported Liquid Extraction Plate; Part Number: 820-0200-P01.
Sample pretreatment: Plasma samples were thawed at room temperature. After vortexing 50 µL of the sample (with or without Zolmitriptan) was aliquoted (or reformatted) into a 96-well plate using a pipette (this step could alternatively be performed using a liquid handler).
Automated processing: The aliquoted sample plate was placed in the Extrahera™ Classic (96 configuration) for extraction. Parameters were set (see Appendix) on the touch screen of the instrument to execute the following procedure:
Add 150 µL 0.5 M NH4OH (aq) (pretreatment solvent) to each
Thoroughly mix the sample with the pretreatment solvent using an aspiration speed of 5 mL/min and a dispense speed of 10 mL/min. Repeat the mixing 3 times.
Transfer 190 µL pretreated mixtures and load onto the 200 µL ISOLUTE® SLE+ plate.
Apply positive pressure (5 bar) for 5 seconds to allow liquid to adsorb into the ISOLUTE® SLE+ sorbent.
Wait for 5
Add 500 µL methyl tert-butyl ether (MTBE) to elute the fraction that contains the analyte into the collection
Allow flow through by gravity for 2
Apply positive pressure at 5 bar for 60 seconds to push all the solvent into the collection plate.
The elution plate was transferred from the Extrahera™ Classic to the TurboVap® 96 Dual evaporator and used the following parameters: N2 flow, 40 L/min; temperature, 25 °C (gas) and 40 °C (plate); plate height, 64 mm. The elution fraction (in MTBE) was dried and then reconstituted using 400 µL ACN/ Water (5:95, v/v) with 0.1% formic acid for LC-MS/MS analysis.
Instrument: Shimadzu Nexera X2
Column: Restek Ultra AQ C18 3 µm 100 x 2.1 mm CAT # 9178312
Mobile phase:
Flow rate: 0.4 mL/min
Elution gradient:
|
Time |
B% |
Gradient |
|
0.10 |
2.5 |
isocratic |
|
1.50 |
2.5 |
isocratic |
|
2.60 |
100 |
linear |
|
3.60 |
100 |
isocratic |
|
3.61 |
2.5 |
isocratic |
|
5.50 |
2.5 |
stop |
Column Temperature: 40 °C
Injection Volume: 5 µL
Autosampler Temp: 15 °C
Instrument: Sciex 5500 MSD
Source temp: 550 °C
IonSpray voltage (IS): 5500 kV
Curtain gas: 40 Collision Gas (CAD): 8
Ion source gas 1: 60
Ion source 2: 60
Ion pair for MRM acquisition: 288.1 (Q1 mass, Da)/58.1 (Q3 mass, Da)
Acquisition parameters: DP: 70 V, EP: 10 V, CE: 45 eV, CXP: 10 V,
Dwell time: 50 msec
The Zolmitriptan spiked plasma was used to evaluate the performance of the ISOLUTE®SLE+ automation workflow for sample preparation in bioanalysis. Our workflow offers ~80% analyte recovery (without internal standard), eliminates matrix effects (~100 %), excellent precision (RSD <6%), and accuracy (with error <± 6%) within and between plates. More importantly, it provides user-friendly automation, significantly shortening the method editing and analyst’s bench labor time.
SLE is designed for extracting analytes that prefer organic to aqueous by retaining the polar matrix components on the support material and letting the organic analytes pass through with extraction solvents (Figure 3). To ensure the analyte is more favored by the organic solvent than aqueous, we pretreated the plasma with 0.5 M NH3OH solution (pH > 11) to keep Zolmitriptan (pKa 9.64 and Log P 2.2) in a non-ionized state.
MTBE and ethyl acetate (EA) were assessed as elution solvents (Table 1), showing comparable performance. MTBE is slightly better in minimizing the matrix effect, while ethyl acetate is slightly better in recovery. The overall results for the analyte can be further improved if the isotopic labeled internal standard is used in the analysis.
Table 1. Selection of elution solvent: MTBE vs. Ethyl acetate
|
Level |
MTBE |
EA |
|
Recovery (%) |
77 |
81 |
|
QC low (8 ng/mL) |
|
|
|
Matrix effect |
101 |
112 |
|
Recovery (%) |
85 |
84 |
|
QC mid (60 ng/mL) |
|
|
|
Matrix effect |
99 |
119 |
|
Recovery (%) |
82 |
87 |
|
QC high (85 ng/mL) |
|
|
|
Matrix effect |
102 |
114 |
Plasma (Human K2EDTA) spiked with different concentrations of Zolmitriptan (from 1-100 ng/mL) were used for the calibration curve and processed identically with the described workflow. The extracted calibration standards were run at the beginning and repeated at the end of the sequence of batch samples. The range of spiked concentrations was selected based on the published results about the in vivo concentrations of Zolmitriptan1. The regression was established by plotting the spiked analyte concentrations against the determined peak areas. We compared the calibration curves run on 3 plates of different batches on different days (Figure 4) and obtained good reproducibility with satisfactory R (>0.998) in linearity.
Equations:
Plate1(blue): y=42173 x + 27830 (R=0.9982); Plate2 (orange): y=47984 x + 37269 (R=0.9989); Plate3 (gray): y= 34855 x + 58662 (R=0.9993)
Three levels of QC samples with spiked analyte concentrations (ng/ml) at 8, 60, and 85 were analyzed to evaluate the accuracy and precision within and between the ISOLUTE® SLE+ plates of different batches (Table 2).
Table 2. Intra- and Inter-Plate accuracy and precision
|
Level |
Intra plate |
Inter plate |
|
|
QC low (8 ng/mL) |
Accuracy (%) |
102.0 |
101.3 |
|
Precision, RSD (%) |
4.8 |
6.0 |
|
|
QC mid (60 ng/mL) |
Accuracy (%) |
105.6 |
105.8 |
|
Precision, RSD (%) |
3.4 |
6.0 |
|
|
QC high (85 ng/mL) |
Accuracy (%) |
105.8 |
105.8 |
|
Precision, RSD (%) |
3.3 |
4.0 |
The experiments were conducted in parallel on 3 plates (each from a different batch) with 3 replicates at each level. Accuracy reflects the trueness of the determined value and is calculated as the percentage between the determined concentration and the spiked concentration. The precision here reflects the reproducibility of determined results and is calculated as the relative standard deviation (RSD, %) of the determined concentration in sample replicates within- and between plates.
Without internal standards, we still received excellent precision (3.3-6.0 %) and accuracy (101.3-105.8 %) within and between the plates. Based on the small number of samples tested in the current study, the ISOLUTE® SLE+ workflow offers comparable results to the traditional protein precipitation method in recovery and accuracy (Table 3).
Table 3. Comparisons between the protein precipitation and the Biotage ISOLUTE® SLE+ automated workflow.
|
|
ISOLUTE® SLE+ workflow |
Protein precipitation |
|
Precision, RSD (%) |
3.4 |
1 |
|
Accuracy (%) |
105.6 |
95.9 |
The precision and accuracy are based on the QC-mid samples (n=3) and calculated in the way described in Table 2.
However, because components in the biomatrix are not extracted by the elution solvents but retained in the aqueous layer suspended on the sorbent, the SLE method can effectively remove the biomatrix interference, eliminating signal suppres- sion in the LC-MS analysis. Figure 5 shows the ISOLUTE® SLE+ effectively removed phospholipids, which were co-extracted by the protein participation method. In actual bioanalysis studies involving multiple batches and hundreds of testing samples, clean sample preparation can greatly reduce signal attenuation, extend the lifetime of the chromatography column, and decrease instrument maintenance downtime.
Figure 5. Phospholipids removal by ISOLUTE® SLE+ in plasma.
The phospholipid profile was monitored by the MRM transition Q1, 184, Da/ Q3, 184, Da using the same LC condition as samples2.
Based on the built-in SLE (and SPE) workflow module, Biotage® Extrahera™ offers user-friendly touch-screen automation without requiring computer programming skills. Step-by-step guidance for method editing and sample running in Extrahera™ Classic is shown in the Appendix. The success of automation relies on well-tuned offline extract/elute methods and a good understanding of the physical properties of the matrices (e.g., viscosity). To ensure the liquid transfer accuracy and avoid generating bubbles, we changed several parameters. We slowed the aspiration flow to 5 mL/min and the dispense flow rates to 10 mL/min for the sample type (plasma) in the transfer and mixing step. The dispense flow rate for the pretreatment solvent (0.5 M NH4OH) was also decreased to 5 mL/min. While the total experiment time for this workflow to process a 96-well plate took about 102 min, the actual bench operation time has been reduced to ~66 min. Scientists’ bench operation time can be further shortened for laboratories that use liquid handlers to perform sample aliquots and reconstitution (Figure 2).
The ISOLUTE® SLE+ automation workflow demonstrated excellent performance in matrix effect, recovery, linearity, accuracy, and precision for bioanalysis. The Extrahera™ Classic’s user-friendly touch-screen operating interface and walk-away automation can greatly improve the efficiency of bioanalytical laboratories.
|
Part Number |
Product |
Qty |
|
820-0200-P01 |
ISOLUTE® SLE+ 200 µL Supported Liquid Extraction Plate |
1 |
|
414001 |
Biotage® Extrahera™ Classic |
1 |
|
416990 |
GLP package |
1 |
|
414141 |
1000 µL Clear Tips |
960 |
|
121-5202 |
Collection Plate, 1 mL Square |
50 |
|
418000 |
TurboVap® 96 Dual |
1 |
|
19-060 |
Biotage® Lysera |
1 |
|
19-8005B |
Cryo Cooling Unit |
1 |
|
PPM-96 |
Biotage® PRESSURE+ 96 Positive Pressure Manifold |
1 |
Step-by-step guidance for setting methods and running samples in Biotage® Extrahera™ Classic using the ISOLUTE® SLE+ 200 µL Plates. The total time needed to complete adding a method is about 15 min.
Step 1: Create a sample type for plasma with updated parameters.
We used plasma in this study. The following settings are based on the plasma’s features to ensure liquid transfer accuracy.
1.1 Go to the home screen and select Data Administration.
1.2 Under the “Data Administration” profile, choose “Manage Sample Types”.
1.3 Select “Aqueous Sample” and click “copy”.
The default setting in the Extrahera does not include the option of “Plasma”. To create a new sample type as plasma, we chose the closest sample type, “Aqueous sample,” copied it, and then made changes to it.
1.4 Update the setting for plasma samples.
1.5 Review the created plasma sample.
Repeat steps 1.1 and 1.2; you will see “plasma sample” in the sample type list.
Step 2. Create a solvent type for pretreatment solvent with updated parameters.
In this study, we wanted to update the dispense flow rate for the pretreatment solvent (0.5M ammonium hydroxide) to avoid bubbles.
2.1 Go to the home screen and select Data Administration.
2.2 Under the “Data Administration” profile, choose “Manage Solvent Types”.
2.3 Select “0.5 M NH4OH” and click “copy”.
2.4 Update the settings for Solvent.
Step 3: Develop SLE methods for automation.
3.1 Go to the home screen and select Manage Methods.
3.2 Choose New Method and Select SLE as the Method Type.
3.3 Edit the SLE method for Zolmitriptan analysis.
We suggest the user do preliminary work offline to optimize the analyte-related conditions (e.g., the sample volume, pretreat- ment solvent, and elution/extraction solvent) before moving to automation. The demonstrated information is related to Zolmitriptan and the current study design.
The user can choose to start a new method or make changes to the existing method.
3.3.1 Edit the sample page.
3.3.2 Edit the pretreatment procedures.
3.3.3 Edit the sample loading procedures.
3.3.4 Edit the elution procedures.
3.3.5 Review the report (Only available in the optional GLP package).
1. Go to the home screen and select Run Method.
2. Select the Developed Method to Run and click Prepare Run
3. Define sample, solvent, and tips information, and start Run
Literature Number: AN989